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ABSTRACT 
The purpose of this investigation was to assess the merit of sports compression socks in 
minimizing travel-induced performance, physiological, and hematological alterations in elite 
female volleyball athletes. Twelve elite female volleyballers (age, 25 ± 2 y) travelled from 
Canberra (Australia) to Manila (Philippines), and were assigned to one of two conditions; 
compression socks (COMP, n = 6) worn during travel, or a passive control (CON, n = 6). 
Dependent measures included counter-movement jump (CMJ) performance, subjective ratings 
of well-being, cardiovascular function, calf girth, and markers of blood clotting, collected 
before (-24 h, CMJ; -12 h, all measures), during (+6.5 h and +9 h, subjective ratings and 
cardiovascular function), and after (+12 h, all measures except CMJ; + 24 h and + 48 h, CMJ) 
travel. As compared with CON, small-to-large effects were observed for COMP to improve 
heart rate (+9 h), oxygen saturation (+6.5 h and +9 h), alertness (+6.5 h), fatigue (+6.5 h), 
muscle soreness (+6.5 h and +9 h), and overall health (+6.5 h) during travel. After travel, small-
to-moderate effects were observed for COMP to improve systolic blood pressure (+12 h), right 
calf girth (+12 h), and CMJ height (+24 h), mean velocity (+24 h), and relative power (+48 h), 
as compared with CON. COMP had no effect on markers blood clotting. This study suggests 
that compression socks are beneficial in combating the stressors imposed by long-haul travel 
in elite athletes, and may have merit for individuals frequenting long-haul travel and/or 
competing soon after flying. 
Keywords: Travel fatigue, jet lag, circadian, team sport, elite athletes.  
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INTRODUCTION 
Travelling away from home for training and competition is standard practice for elite 
athletes across numerous sports. Frequent long-haul air travel is often unavoidable (10), a 
practice that has been reported to impair athletic performance (35). Circadian dysrhythmia, or 
‘jet lag’, is a common occurrence for the travelling athlete and often manifests as a general 
feeling of tiredness, sleep disruption, a lack of concentration and motivation, and/or decreased 
mental and physical performance (44). Jet lag is typically associated with individuals rapidly 
travelling across three or more meridian time zones (32); however performance decrements 
have also been suggested to occur when as few as two time zones are traversed (5). Symptoms 
of jet lag may persist until re-synchronization to the new environment occurs (44), and recovery 
time is considered to be dependent on the number of time zones crossed (30).  
Another potential complication for athletes during air travel following training and 
competition is the development of venous thromboembolisms (VTE), consisting of either 
pulmonary embolisms or deep vein thrombosis (DVT) (18, 41). The limited space (1), cramped 
seating arrangements (23), and hypobaric hypoxic environment (4, 37) experienced in airline 
cabins may contribute to the slowing of venous circulation (4), promoting venous stasis, pro-
coagulant activity, and inhibition of fibrinolysis (i.e., breakdown and removal of blood clots) 
(23). Furthermore, the risk of a thromboembolic event occurring is compounded by underlying 
and acquired risk factors associated with hypercoagulability, including oral contraceptive use, 
frequent long-haul travel, and/or genetic predisposition to hypercoagulability (e.g., 
prothrombin G22010A and Factor V Leiden mutations) (33). The successful treatment of a 
thrombotic embolism may take months to resolve, limiting the athlete’s participation whilst 
impacting negatively on team competition planning and performance (15).  
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In addition to flight-induced thrombosis, VTE risk is exacerbated in athletes as a result 
of the large volume and high intensity exercise typically performed. While physical activity 
and exercise appear to be protective against thromboembolic disorders (1), it has been reported 
that exhaustive exercise, particularly long durations and/or high intensities, may enhance 
activation of the blood coagulation system (15), resulting in an increased risk for thrombosis 
development (1). Indeed, the mode, volume, and intensity of training undertaken by some elite 
athletes has been recognized as a cause of “effort thrombosis” (Paget-Schroetter syndrome) 
(17), as evidenced by a number of case reports documenting the development of VTE in 
athletes (6, 14, 41). It has been reported that 1 in 1000 athletes will experience a post-exercise 
thrombotic event (22), 40% of which may develop post-thrombotic syndrome (PTS) (38). 
Symptoms of PTS include chronic leg pain, leg heaviness, leg swelling, and leg cramping (38). 
In conjunction with other athlete-related risk factors (e.g., recent orthopedic trauma and 
surgery, limb immobilization, dehydration and hemoconcentration after exercise, and/or 
altitude training), frequent and/or prolonged air travel following exhaustive exercise may 
significantly contribute to an increased risk of thrombosis and PTS in trained athletes (1). 
Currently, the use of compression garments is the most accepted and commonly 
available method of external compression for the prevention of flight-related thrombosis (23). 
Associated benefits include blood vessel dilation, reduced lower-limb swelling, and increased 
blood flow/venous return (31), as well as an inhibition in the outflow of blood through the 
endothelial gaps (i.e., subsequent contact with tissue factors and initiation of coagulation) (37). 
These improvements in resting circulatory dynamics may also increase muscle oxygenation 
and/or improve muscle repair from confined stress configurations (8, 42), and as a result 
minimize the detrimental effects of long-haul air travel on exercise performance in travelling 
athletes (28). In support of this, wearing compression during long-haul trans-meridian air travel 
has been reported to maintain counter-movement jump performance (28), as well as improve 
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subjective ratings of leg pain, discomfort, energy levels, ability to concentrate, and alertness 
(21), as compared with a passive control.  
The use of compression garments during international air travel may therefore reduce 
the risk of travel-related performance decrements and thrombosis, but this has not been 
investigated in an elite population following long-haul air travel. Given that long-distance air 
travel is regularly frequented by the modern-day elite athlete (10), as well as the exacerbated 
risk for athletes to develop VTE (1), this is an important and unanswered omission in the 
literature. The aim of the current study was to determine the effects of wearing compression 
socks during long-haul travel on sports-specific performance, physiological, and hematological 
alterations in elite female volleyball athletes, thereby assessing its potential as an effective 
means to minimize the detrimental effects of air travel on travelling athletes. We hypothesized 
that wearing compression socks during long-haul travel would minimize the detrimental effects 
of long-haul air travel on exercise (counter-movement jump) performance, markers of VTE, 
and subjective ratings of travel fatigue and jet-lag.  
METHODS 
Experimental Approach to the Problem 
To examine the effects of wearing compression socks during long-haul air travel on 
performance, physiological, and hematological alterations in elite female volleyballers, athletes 
travelling from Canberra (Australia) to Manila (Philippines) for the Women’s Asian 
Championships (August, 2017) volunteered as participants. The study followed a two-group, 
parallel study design, in which participants were assigned (in a randomized and counter-
balanced fashion) to one of two conditions; compression socks (COMP, n = 6), or a passive 
control (CON, n = 6). Participants were matched for counter-movement jump (CMJ) height, 
and required to wear compression (COMP) or normal (CON) socks underneath a loose-fitting 
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team tracksuit for the duration of travel. Within-subject difference in performance, 
physiological, and hematological alterations were compared over time (before, during, and 
after travel) and between groups (COMP v CON).  
Subjects 
Twelve elite Australian female volleyball athletes (mean ± SD: age, 25 ± 2 y and range 
22 to 27 y; body mass, 78.9 ± 4.5 kg; years competing at international level, 5 ± 2 y) completed 
the study. As confirmed by the coaching staff, the team was in a tapering phase leading up to 
the Asian Championships. Participants were first provided with an institutionally-approved 
informed consent form presenting all the information pertinent to the investigation, and were 
also verbally informed of the benefits and risks of the investigation. If the participants agreed 
to participate in the study, they were then requested to sign the informed consent form. All 
participants were screened for cardiovascular risk factors that may increase the risk of an 
adverse event occurring during exercise. All experimental procedures were approved by the 
Australian Institute of Sport’s (AIS) Human Research Ethics Committee, and adhered to the 
American College of Sports Medicine’s policies with regards to human experimentation. All 
participants had no known history or clinical signs of coagulation disorders or previous history 
of VTE. Participants were asked to refrain from nicotine, alcohol, and caffeine consumption 
for 24 h prior to each testing session, as monitored by 24 h food diaries. Given the implications 
of diet, and especially fat, on blood hemostasis (34), participants were also provided with 
dietary recommendations to adhere to during the study (e.g., consistent dietary fat content). In 
addition, participants were asked to avoid the use of anti-coagulant (i.e., aspirin, heparin, and 
warfarin) and non-steroidal anti-inflammatory medications for at least two weeks before, and 
throughout, the testing period. 
 
Compression and Air Travel in Athletes - 7 
 
Procedures 
An outline of the experimental procedures is demonstrated in Figure 1. Participants first 
reported to the AIS Physiology Laboratory 24 h prior to travel (-24 h). During this session, 
familiarization and baseline testing of the counter-movement jump (CMJ) protocol was 
performed. On the same day (-12 h) after a day of training and a recovery session, baseline 
measures of CMJ performance, subjective ratings of well-being, cardiovascular function, calf 
girth, as well as a blood sample, were collected. This time point was chosen as baseline so as 
to minimize diurnal variation between the baseline and post-flight measures (i.e., both were 
performed at a similar time of day, ~1600 AEDT). On the next morning, participants reported 
to Canberra Airport to begin travel (0800 AEDT). Prior to boarding, participants assigned to 
the COMP group were presented with knee-high sports compression socks (2XU Compression 
Socks, Melbourne, Australia), to be worn for the entire duration of travel (i.e., Canberra to 
Manila). These compression socks have previously be reported to elicit compression of 23 ± 
11 mmHg at the maximal calf girth, and between 19 and 22 (± 8) mmHg at the ankle, in well-
trained runners (9). Subjective ratings of well-being and cardiovascular function were taken at 
2.5 and 5 h into the Sydney-Manila flight leg, corresponding to 6.5 h (+6.5 h) and 9 h (+9 h) 
after the start of travel. Upon arrival to the hotel in Manila, all baseline (-12 h) measures were 
repeated. Physical performance measures were also collected for two days (+24 h and +48 h) 
after landing in Manila. All morning testing sessions (Canberra and Manila), were performed 
at the same time of day (0800 AEDT) to minimize diurnal variation. 
*** FIGURE 1 ABOUT HERE*** 
Flight Details 
Participants, coaching staff, and the testing personnel travelled from Canberra to Manila with 
Qantas Airlines (Qantas, Sydney, Australia). The total flight duration was ~9.5 h, divided into 
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two legs; 1) QF 1494 (De Havilland-Bombardier Dash-8), ~1 h Canberra to Sydney; 2) QF 19 
(Airbus A330), ~8.5 h Sydney to Manila, with a ~2.5-h stop-over in Sydney. Participants sat 
in economy class for both flights (Seat Width/Pitch 46/79-81 cm), and a total of 2 time zones 
were crossed from Sydney to Manila. Cabin temperature was maintained at ~ 23° C, and the 
cabin was pressurized to a maximum altitude of 2440 meters (minimum pressure of 75 kPa). 
Participants were instructed to ‘move (their) legs and feet for three to four minutes per hour 
while seated’, but to avoid excessive movement throughout the cabin (apart from necessary 
toilet breaks). Meals were provided on the Sydney-Manila leg only, comprising of lunch, and 
afternoon snack, and an evening meal prior to arrival. During the flight, participants were 
instructed to avoid alcohol and caffeine consumption, and to consume 500 mL of water every 
2 h to ensure adequate hydration. All participants were informed that hydration during air travel 
will maintain blood volume, thereby limiting the risk of blood clotting and its subsequent effect 
on exercise performance. As such, this recommendation ensured adequate hydration during air 
travel, but also doubled as an attempt to limit the effects of a potential placebo effect on 
performance. 
Pre-Flight Training and Recovery Sessions 
On the day prior to travel, the 12 volleyball athletes performed two training sessions at 
the AIS in preparation for an upcoming tournament (2017 Women’s Asian Championships). 
The first training session (0830 to 1030 AEDT) was a moderate-to-high intensity (~session 
RPE 5 to 6) session, comprising of mobility/warm-up (15 min), ball control drills (15 min), 
skill-based drills (30 min) and 6-on-6 game play (1 h), and was completed immediately after 
the baseline measures. This session had a jump focus, in that hitters and setters performed 
approximately 90 to 120 and 150 to 200 jumps during the 2-h session, respectively. The second 
training session (1430 to 1530 AEDT) was a low-intensity (~session RPE 2 to 3), skill-based 
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session, compromising of serve and pass drills only. Immediately after the second training 
session, participants performed a 30-min recovery session, comprising of 10 min of 
hydrotherapy at the AIS Recovery Centre (4 min active recovery in 25˚ C, 3 min passive in 37 
˚ C, and 3 min passive in 17 ˚  C) and 20 min of compression therapy of the legs using pneumatic 
compression boots (Normatec PULSE Leg Recovery System, Normatec, Watertown, MS, 
United States). 
Counter-Movement Jumps 
To assess the effects of travel on volleyball-specific performance, participants 
performed maximal counter-movement jumps (CMJ) on four occasions: twice during baseline 
testing (-24 h and -12 h), the morning after landing in Manila (+24 h), and the following 
morning (+48 h). Before the CMJ protocol, participants completed a standardized warm up of 
5 lunges per leg, 5 body weight squats, 5 tuck jumps, 3 CMJ (bar on shoulders) at 70% maximal 
effort, 3 CMJ (bar on shoulders) at 90%, and 2 CMJ (bar on shoulders) at 100%. For the CMJ 
protocol, a position transducer (GymAware, Kinetic Performance Technology, Canberra, 
Australia) was connected to a lightweight bar (~400 g) held across the posterior deltoids at the 
base of the neck. Starting from the initial standing position (upright position with feet 
approximately shoulder width apart), participants lowered themselves to a self-selected depth 
and then jumped for maximal height with no pause between eccentric and concentric 
movements [24]. Encouragement was provided such that participants were to be as explosive 
as possible in their movements, and jump as high as possible (n.b., the bar was to remain firmly 
against shoulders at all times for the CMJ). Each athlete completed 5 maximal jumps, with 
peak jump height (m), mean concentric velocity (m/s), relative power (W/kg), and jump-to-dip 
height (ratio) used for analysis. These measures were chosen to demonstrate the recovery of 
volleyball-specific performance, namely lower-body power production. Baseline CMJ (-24 h 
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and -12 h) were performed in the AIS Physiology Laboratory, whereas post-travel CMJ (+24 
h and +48 h) were performed on the teams training court in Manila. All CMJ were performed 
away from the main group (i.e., other participants and coaches) so as to remove the effects of 
social facilitation on jump performance.  
Jet Lag Questionnaire 
To assess the effects of travel on psychological well-being, participants were required 
to complete an adapted version of the Liverpool Jet Lag questionnaire (JLQ) at a number of 
time points during the study. The JLQ was designed to assess participant feelings of jet lag, 
ability to concentrate, mood, fatigue levels, muscle soreness, motivation, and overall health. 
Instructions were given to mark an “X” on a 10-cm visual analog scale between two extremes 
(0 = ‘not at all jet lagged’, ‘focused’, ‘amicable’, ‘not fatigued at all’, ‘not sore at all’, 
‘extremely motivated’, and ‘very healthy’; 10 = ‘extremely jet lagged’, ‘easily distracted’, 
‘antagonistic’, ‘extremely fatigued’, ‘extremely sore’, ‘not motivated at all’, and ‘not healthy 
at all’). The questionnaire was completed at baseline (-12 h), during the Sydney to Manila flight 
(+6.5 h and +9 h), and post travel (+12 h).  
Cardiovascular Function 
Upon arriving to the AIS laboratory for baseline testing, participants were asked to be 
seated for 15 min. Following this, resting blood pressure and heart rate (HR; UB-542 Wrist 
Blood Pressure Monitor, A&D), and oxygen saturation (SO2; Onyx Vantage 9590 Finger Pulse 
Oximeter, Nonin) were measured. Following 15 min of seated passive rest on each occasion, 
these measures were again taken during the Sydney to Manila flight (+6.5 h and +9 h), and post 
travel (+12 h). These measures were used as surrogate markers of compression-induced 
changes in blood flow. 
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Calf Girth 
Used as an objective measure of lower-limb swelling, calf girth measurements were 
obtained during baseline testing at the AIS (-12 h) and upon arrival at the team’s hotel in Manila 
(+ 12 h). On both occasions, calf girth measurements were taken immediately after the 
cardiovascular function measurements. With the participants standing, an Executive steel tape 
measure (Lufkin, USA) was used to measure calf girth as per the International Standards for 
Anthropometric Assessment guidelines (40). Girth measurements were repeated twice and the 
average of two measures per site were used for data analysis. Following the baseline measures, 
a mark was made on the participant’s calf to ensure the same site was used for the post-travel 
measurement. 
Blood Samples 
Venous blood samples (~10 mL) were drawn without stasis by venipuncture from the 
antecubital fossa on two separate occasions; during baseline testing at the AIS (-12 h), and at 
the hotel in Manila (+12 h). Blood samples were collected into sodium citrate Vacutainers® 
(Becton Dickinson, New Jersey, USA). Baseline samples were spun for 15 min at 4° C and 
1000 g in a centrifuge (CF 20-R, Awel Centrifugation, Blain, France), and collected plasma 
was aliquoted and stored at -20° C for subsequent analysis. Blood collected at the hotel in 
Manila was spun for 15 min at 4° C and 1000 g using a portable centrifuge (EBA 20, Hettich, 
Tuttlingen, Germany), with the aliquoted plasma stored at 4° C for 24 h until couriered back to 
the AIS (World Courier, Stamford, CT, United States) for subsequent storage at –20° C. All 
samples were subsequently thawed and analyzed for markers coagulation and fibrinolytic 
activity in the blood, thereby providing including tissue factor (TF), tissue factor pathway 
inhibitor (TFPI), thrombin anti-thrombin complex (TAT), and D-Dimer with commercially 
available enzyme-linked immunosorbent assay (ELISA) kits (Abcam, Melbourne, Australia), 
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according to manufacturer’s guidelines. All samples were measured in duplicate using a 
spectrometer-based absorbance microplate reader (SPECTROstar Nano, BMG Labtech, 
Offenburg, Germany).  
Statistical Analyses 
The data were analyzed with a linear mixed model using IBM SPSS Statistics V19 
(IBM Corporation, USA). A random intercept for subjects was included to account for intra-
individual dependencies and inter-individual heterogeneity. This also allowed for individual 
baseline adjustment. Fixed effects for time, condition, and their interaction (time x condition) 
were analyzed, and all models were estimated using Restricted Maximum Likelihood. The 
level of significance was set at P < 0.05. Data are presented as mean estimates and 95% 
confidence intervals, unless otherwise stated. To complement the statistical hypothesis testing, 
effect sizes (ES) were calculated to assess the practical significance of changes (from baseline) 
in calf girth, hematological markers, autonomic function, subjective ratings and physical 
performance between conditions. Effects of compression on these factors were log transformed 
before analysis (to permit the effect of the treatment to be analyzed as factors or percent), and 
magnitudes of effects were determined by standardization of the log-transformed variable. 
Performance outcomes were assessed by standardization; 0.20 of the pooled between-subject 
standard deviation in the two groups. Differences between group means of subject 
characteristics were assessed with a modification of Cohen's scale for standardized effects 
(small, 0.20-0.60; moderate, 0.60-1.20; large, >1.20). ES were only reported when there was a 
≥ 75% likelihood of the effect being equal to or greater than the smallest worthwhile change 
(ES = 0.2), and uncertainty in the estimates are reported as 90% confidence intervals. All ES 
were calculated using a custom excel spreadsheet [4].   
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Calculated intra-class correlation coefficients (ICCs), considering the average for all 
variables analyzed, demonstrated excellent reliability for CMJ height (ICC = 0.90), CMJ mean 
velocity (ICC = 0.91), D-Dimer (ICC = 0.943), TF (ICC = 0.97), TAT (ICC = 0.96), HR (ICC 
= 0.92), L calf girth (ICC = 0.98), and R calf girth (ICC = 0.94), good reliability for CMJ peak 
power (ICC = 0.84), CMJ jump to dip ratio (ICC = 0.86), TFPI (ICC = 0.79), and SBP (ICC = 
0.77), and poor reliability for oxygen saturation (ICC = 0.32) (27).  
RESULTS 
Counter-Movement Jumps 
There were no time or interaction effects for CMJ height (P = 0.717 and 0.942), mean 
velocity (P = 0.466 and 0.800), relative power (P = 0.331 and 0.675), or jump to dip height 
ratio (P = 0.457 and 0.991) (Fig. 2). However, when compared with CON, effect size analysis 
revealed that CMJ height (5.2 ± 6.1%; ES = 0.69 ± 0.66) and mean velocity (3.9 ± 5.0%; ES = 
0.55 ± 0.70) were higher for COMP at +24 h. Similarly, CMJ relative power was 8.0 ± 9.2% 
higher for COMP, as compared with CON, at +48 h (ES = 0.74 ± 0.84) (Fig. 2).  
*** FIGURE 2 ABOUT HERE*** 
Jet Lag Questionnaire 
There was a main effect of time (P < 0.001) for jet lag, in that all participants felt 
significantly jet lagged after travel (+12 h). There were no main effects of time for subjective 
ratings of alertness (P = 0.186), mood (P = 0.636), fatigue (P = 0.247), muscle soreness (P = 
0.671), motivation (P = 0.875), or overall health (P = 0.636). There were no interaction effects 
for jet lag (P = 0.853), alertness (P = 0.679), mood (P = 0.853), fatigue (P = 0.712), muscle 
soreness (P = 0.689), motivation (P = 0.872), or overall health (P = 0.853). However, effect 
size analysis revealed that changes from baseline in subjective ratings of alertness, fatigue, 
muscle soreness, and overall health were all improved for COMP, as compared with CON. 
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Specifically, fatigue (ES = 1.07 ± 1.68), muscle soreness (ES = 0.66 ± 0.90), and overall health 
(ES = 0.35 ± 0.37) were all improved at +6.5 h, with alertness (ES = 0.75 ± 1.48) and muscle 
soreness (ES = 1.27 ± 1.44) both improved at +9 h (Table 1).  
*** TABLE 1 ABOUT HERE*** 
Cardiovascular Function 
There was a main effect of time for SO2 (P < 0.001), which was significantly reduced 
at +6.5 h (P = 0.003) and +9 h (P < 0.001). There were no main effects of time for systolic 
blood pressure (SBP; P = 0.469) or HR (P = 0.891), nor interaction effects for SBP (P = 0.741), 
HR (P = 0.839), or SO2 (P = 0.719). However, effect size analysis revealed that changes from 
baseline in SBP at +12 h (8.1 ± 12.2 %; ES = 0.64 ± 0.87), HR at +9 h (9.3 ± 12.7 %; ES = 
0.71 ± 0.87), and SO2 at +6.5 h (1.1 ± 2.6 %; ES = 1.90 ± 4.49) and +9 h (1.2 ± 2.1 %; ES = 
2.20 ± 3.77), were higher (SO2) or lower (SBP and HR) for the COMP condition as compared 
with CON (Fig. 3).  
*** FIGURE 3 ABOUT HERE*** 
Calf Girth 
There were no main time or interaction effects for left (P = 0.960 and 0.710) and right 
(P = 0.654 and 0.550) calf girth. However, when compared with CON, effect size analysis 
revealed right calf girth to be less (1.7 ± 1.9 %; ES = 0.44 ± 0.51) following travel for the 
COMP condition (Fig. 4). 
*** FIGURE 4 ABOUT HERE*** 
Blood Samples  
There were no time or interaction effects for TF (P = 0.468 and 0.977), TFPI (P = 0.414 
and 0.806), TAT (P =0.549 and 0.997), or D-Dimer (P = 0.494 and 0.796) (Fig. 5).  
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*** FIGURE 5 ABOUT HERE*** 
DISCUSSION 
The primary findings of this study were that sports compression socks maintained 
exercise performance, and reduced lower-limb swelling, when worn during ~8.5 h of air travel 
in elite female athletes, as compared with a control condition (i.e., no compression socks). This 
also coincided with improved subjective ratings of alertness, fatigue, muscle soreness, and 
overall health in participants assigned to wearing compression socks. However, the results 
appear to be independent of altered cardiovascular function (i.e., SBP, HR, and SO2) and/or 
indicators of blood coagulation. 
Recovery of counter-movement jump performance in the days following travel was 
superior in the COMP as compared with CON. Coinciding with improved subjective ratings 
during (mood and soreness) and after (jet lag) air travel, jump height, mean velocity and relative 
velocity were higher for COMP at 24 h (height and mean velocity) and 48 h (relative power) 
after the commencement of travel. Consistent with reports of performance decrements with air 
travel across two time zones (5), it has been suggested that half a day per time zone is needed 
to recover from symptoms of jet lag when travelling westward (26). As such, the 2 hour time 
zone change in the current study (i.e., Sydney to Manila) suggests a full day may have been 
required for athletes to recover fully. In support of this, jump height, mean velocity and relative 
power were all below baseline levels at the 24 h post-travel time point for the CON condition. 
However, the return to baseline for all countermovement jump performance variables 
consistently occurred sooner in the COMP as compared with CON, consistent with CMJ 
performance in non-elite individuals travelling 6 h and 20 min westward from Hartford to Los 
Angeles (three time zones) (28). In this study, Kraemer et al (28) suggest multiple explanations 
for compression to improve the recovery of CMJ performance, including increased muscle 
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oxygenation, improved resting circulatory dynamics, and/or better muscle repair from confined 
stress configurations (8, 42). Although not measured in the current study, sleep disruption may 
have occurred as a result of long-haul travel across multiple time zones (5). Considering the 
participants wearing compression in the current study felt less fatigued and sore during travel, 
it is also possible they had a better night’s sleep post-travel, which may have contributed to the 
superior CMJ performance.  
Improved subjective ratings of alertness, fatigue, muscle soreness and overall health 
reported by the COMP participants may have played a role in improving CMJ performance. 
Individuals travelling over 8 h have previously reported whole-leg compression tights to 
improve ratings of pain, discomfort, energy levels, alertness, and the ability to concentrate (21). 
Consistent with the study by Hagan (21), reduced edema (actual or perceived) may have 
contributed to improved ratings of fatigue and muscle soreness and jet lag in the current study. 
Subsequently, and considering fatigue (36) and muscle soreness (11) are known to effect 
performance, improved ratings of these perceptual measures in the COMP group are likely to 
have contributed to improved CMJ performance.  
As compression has been reported to improve hemodynamic responses at rest (29), we 
also assessed the effects of compression socks on in-flight cardiovascular responses. When 
compared with pre-travel baseline values, in-flight HR for COMP was reduced by ~8.4 % (+9 
h), compared with a negligible increase (~1.3 %) for the CON condition. These data suggest 
that compression of a small area of muscle (i.e., foot and shank) may alter central circulatory 
and cardiac parameters such as HR, cardiac output and SBP, despite previous suggestions (7) 
and data (2) refuting this. In further support that compression may alter HR and subsequently 
cardiovascular strain, SBP was also lower in COMP post-travel as compared with CON.  As 
expected, SO2 was decreased during air travel, most likely as a result of an altitude-induced 
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reduction in the fraction of inspired oxygen (24). However, wearing compression socks during 
travel attenuated the flight-induced decrease in SO2 (+6.5 h and +9 h). Although improved 
venous return has been reported to increase arteriovenous pressure gradient (43) and tissue SO2 
(16), this is the first study to report an increase in SO2 when wearing compression during air 
travel. A hypothetical mechanism for this occurrence is that a compression-induced increased 
in venous return, as evidenced by a lower HR, improved the volume of blood presented at the 
alveolar membranes per beat of the heart, thereby allowing greater saturation levels. Future 
research to confirm the effects of compression on SO2 during air travel is warranted, especially 
considering that reduced SO2 has been implicated in reduced cognitive function in pilots and 
cabin crew (19). 
It is well established that compression garments are an effective strategy to reduce 
flight-induced lower-limb edema (12). Consistent with this, the current study reported a small 
reduction (~0.7 cm; 1.7 %) in right calf girth for the participants who wore compression socks 
during ~9.5 h of air travel. Considering lower-limb edema is a symptom of inadequate venous 
blood flow (21), these data also support the notion that sports compression garments are 
effective in reducing the risk of travel-related thrombosis (e.g., DVT). The external pressure 
applied by compression is thought to decrease vein diameter, thereby increasing deep venous 
velocity/return and reducing the risk of thrombosis forming due to venous pooling (39). Lower-
limb edema may also reduce range of motion in the ankle and knee joints, which in turn may 
have important implications for jump performance (7). Although this is likely to be resolved 
quickly without the presence of exercise-induced muscle damage, this is an important 
consideration for athletes required to compete or train soon after an extended period of 
stationary travel (e.g., car, bus, train and/or airplane).  
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A novel component of this study was to investigate the effects of wearing compression 
socks during long-haul air travel on markers of coagulation and fibrinolysis in elite female 
athletes. We investigated markers of blood coagulation activation (TF) and regulation (TFPI), 
hyper-coagulation (TAT), and thrombosis and fibrinolytic activity (D-Dimer), but found no 
effects of travel or compression for these markers as a result of long-haul travel. A potential 
explanation for these inconsistencies is the training sessions that were performed on the day 
prior to travel. For example, TF and D-Dimer concentrations have been reported to increase by 
up to ~1.9-fold and ~6.5-fold (respectively) in participants following a marathon (45). 
Although the training sessions performed in the current study were of a much shorter duration 
and/or lower intensity than those previously associated with heightened coagulation risk (25, 
45), it is possible that the coagulation markers had already increased. As such, any potential 
increases in these markers as a result of travel may have been masked by prior exercise and 
increased baseline concentrations. For example, TAT has previously been reported to increase 
by ~30% following an 8-h flight in a non-athletic population (37), yet only increased ~6% in 
the current study. Although fibrinolytic activity has been shown to be influenced by circadian 
rhythms (3), baseline and post-travel blood samples were taken at the same time of day 
AEDST, thereby discounting this as a potential confounder. However, since some participants 
are more susceptible to coagulation activation than others (e.g., genetic disposition and/or 
females using oral contraceptives (13, 33)), as well as the increased prevalence of effort 
thrombosis in sports requiring extensive and repetitive use of the upper body (20), these factors 
may have confounded the results of the current study.  
PRACTICAL APPLICATIONS  
The current study suggests that compression socks are beneficial in combating the 
physiological stressors imposed by long-haul travel in elite female volleyball athletes, 
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consistent with improvements reported in recreationally-active individuals following long-haul 
travel across a similar number of meridian time zones (28). These findings translate into a real-
world practical benefits for athletes and coaches, and it is recommended that coaches promote 
the use of compression as a necessary precaution to maximize the capacity and quality of 
training and/or competition performed soon after long-haul air travel. Although the training 
sessions performed prior to travel may have influenced some baseline measures, it is common 
practice for an athlete group to perform a training session on the day before flying, and as such 
the current study also provides an ecologically valid investigation.  
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FIGURE LEGENDS: 
Figure 1: Schematic diagram of the study. Fam; familiarization session; CF, cardiovascular 
function measures; PQ, psychological questionnaires; CMJ, counter-movement jumps; Leg 1, 
Canberra–Sydney flight leg; Leg 2, Sydney–Manila flight leg; blood drop, blood sample. Time 
(h) shown represents the duration before (-) and after (+) travel commenced in Sydney.   
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Figure 2: Counter-movement jump height (A), mean velocity (B), relative power (C), and jump 
to dip height ratio (D) for the control (CON) and compression (COMP) conditions. Values are 
presented as a percentage of baseline (24 h before travel; -24 h), as measured 12 h before (-12 
h), 24 h after (+24 h), and 48 h after (+48 h) travel. All data are presented as mean ± SD. ^ 
Small effect (ES = 0.55 ± 0.70) as compared with CON. # Moderate effect (ES = 0.6-1.2) as 
compared with CON. 
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Figure 3: Systolic blood pressure (A), heart rate (B) and oxygen saturation (C) for the control 
(CON) and compression (COMP) conditions. Time points are before travel (-12 h), 6.5 h into 
travel (+6.5 h), 9 h into travel (+9 h), and post-travel (+12 h). * Significantly lower (P < 0.05) 
than baseline. # Moderate effect (ES = 0.6-1.2) as compared with CON. All data are presented 
as mean ± SD.  
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Figure 4: Calf girth of the left (A) and right (B) limbs, for the control (CON) and compression 
(COMP) conditions. Time points are before (-12 h) and after (+12 h) travel. ^ Small effect (ES 
= 0.2-0.6) as compared with CON. All data are presented as mean ± SD.  
- 1 2  h + 1 2  h
0
3 0
3 3
3 6
3 9
4 2
4 5
L
e
f
t
 C
a
lf
G
ir
t
h
 (
c
m
)
C O N
C O M P
A
T r a v e l
- 1 2  h + 1 2  h
0
3 0
3 3
3 6
3 9
4 2
4 5
R
ig
h
t
 C
a
lf
G
ir
t
h
 (
c
m
)
B
^
T r a v e l
  
Compression and Air Travel in Athletes - 27 
 
Figure 5: Markers of coagulation and fibrinolysis for the control (CON) and compression 
(COMP) conditions, before (-12 h) and after (+12 h) travel. Markers were Tissue Factor (A), 
Tissue Factor Pathway Inhibitor (B), Thrombin-Antithrombin Complex (C), and D-Dimer (D). 
All data are presented as mean ± SD.  
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Table 1: Subjective ratings of jet lag, alertness, mood, fatigue, muscle soreness, motivation, 
and overall health from the jet lag questionnaire (JLQ).  
 Time Point 
 -12 h +6.5 h +9 h +12 h 
Jet Lag     
CON 0.2 ± 0.2 1.5 ± 2.0 1.7 ± 1.7 4.1 ± 2.6* 
COMP 0.1 ± 0.2 1.1 ± 1.8 2.7 ± 2.5 4.4 ± 2.6* 
Alertness     
CON 3.5 ± 2.1 3.8 ± 2.6 5.7 ± 3.2 5.5 ± 2.2 
COMP 4.9 ± 1.6 4.0 ± 2.4 4.8 ± 1.8# 5.9 ± 1.4 
Mood     
CON 1.8 ± 1.6 2.1 ± 2.2 2.6 ± 1.9 3.0 ± 3.0 
COMP 2.2 ± 2.2 1.5 ± 2.1 1.9 ± 2.2 2.9 ± 2.7 
Fatigue     
CON 5.1 ± 2.5 5.3 ± 2.2 5.2 ± 1.8 6.2 ± 1.7 
COMP 6.1 ± 1.6 4.6 ± 2.1# 5.1 ± 1.5 6.6 ± 1.4 
Muscle Soreness     
CON 5.6 ± 2.6 5.5 ± 1.6 5.6 ± 2.2 4.7 ± 2.5 
COMP 5.6 ± 1.7 4.4 ± 1.6# 3.9 ± 2.4# 4.7 ± 1.9 
Motivation     
CON 4.4 ± 2.4 4.3 ± 1.4 4.6 ± 1.6 4.5 ± 2.3 
COMP 4.6 ± 2.6 4.7 ± 2.2 4.4 ± 1.8 5.7 ± 3.0 
Overall Health     
CON 1.8 ± 1.2 1.7 ± 2.0 2.5 ± 1.9 2.4 ± 2.1 
COMP 1.5 ± 0.8 2.6 ± 2.1# 2.3 ± 1.9 2.8 ± 2.3 
Values are arbitrary units from 0-10 on a visual analogue scale, presented as mean ± SD. Time points 
are before travel (-12 h), 6.5 h into travel (+6.5 h), 9 h into travel (+9 h), and post-travel (+12 h). * 
Significantly different to baseline (P < 0.05). # Moderate effect (ES = 0.6-1.2) as compared with CON.  
